"Dobutamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
| Descriptor ID |
D004280
|
| MeSH Number(s) |
D02.092.311.220 D02.092.471.683.410
|
| Concept/Terms |
Dobutamine Tartrate- Dobutamine Tartrate
- Tartrate, Dobutamine
- Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer
|
Below are MeSH descriptors whose meaning is more general than "Dobutamine".
Below are MeSH descriptors whose meaning is more specific than "Dobutamine".
This graph shows the total number of publications written about "Dobutamine" by people in this website by year, and whether "Dobutamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 2 | 4 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dobutamine" by people in Profiles.
-
Dobutamine stress cardiac MRI is safe and feasible in pediatric patients with anomalous aortic origin of a coronary artery (AAOCA). Int J Cardiol. 2021 Jul 01; 334:42-48.
-
Burn-induced cardiac dysfunction increases length of stay in pediatric burn patients. J Burn Care Res. 2013 Jul-Aug; 34(4):413-9.
-
Brain tissue oxygenation-guided management of diabetic ketoacidosis induced cerebral edema*. Pediatr Crit Care Med. 2012 Nov; 13(6):e383-8.
-
Cardiomyopathy in a-kinase 3 (ALPK3)-deficient mice. Vet Pathol. 2012 Jan; 49(1):131-41.
-
Divergent effects of NO synthase inhibition on systemic and myocardial O2 delivery and consumption during dobutamine infusion in sheep. Pflugers Arch. 2002 Feb; 443(4):601-8.
-
Increased systemic oxygen consumption offsets improved oxygen delivery during dobutamine infusion in newborn lambs. Intensive Care Med. 2001 Sep; 27(9):1518-25.
-
Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients. Am J Cardiol. 2001 Sep 01; 88(5):583-6.
-
A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure. Chest. 2001 Aug; 120(2):460-6.
-
Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial function. Circulation. 2000 Nov 21; 102(21):2599-606.
-
Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Circulation. 2000 Nov 07; 102(19 Suppl 3):III154-9.